# Nivolumab With Vismodegib in Patients With Basal Cell Nevus Syndrome

> **NCT03767439** · PHASE2 · WITHDRAWN · sponsor: **Columbia University**

## Conditions studied

- Basal Cell Nevus Syndrome

## Interventions

- **DRUG:** Vismodegib
- **DRUG:** Nivolumab
- **DRUG:** Ipilimumab

## Key facts

- **NCT ID:** NCT03767439
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-07
- **Primary completion:** 2019-12
- **Final completion:** 2020-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Loss of funding
- **Last updated:** 2019-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03767439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03767439, "Nivolumab With Vismodegib in Patients With Basal Cell Nevus Syndrome". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT03767439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*